These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6102774)

  • 61. The quest for the correct dose.
    Glazer WM
    Behav Healthc; 2010 Sep; 30(8):38, 40. PubMed ID: 21114244
    [No Abstract]   [Full Text] [Related]  

  • 62. Reply: To PMID 20388858.
    Walthour A; Seymour L; Tackett R; Perri M
    Ann Pharmacother; 2011 Feb; 45(2):283-4. PubMed ID: 21304023
    [No Abstract]   [Full Text] [Related]  

  • 63. The recommended dosage range: how is it established and why would it ever be exceeded?
    Preskorn SH
    J Psychiatr Pract; 2004 Jul; 10(4):249-54. PubMed ID: 15552547
    [No Abstract]   [Full Text] [Related]  

  • 64. Double-blind or single-blind?
    Brody I
    N Engl J Med; 1973 Feb; 288(5):267-8. PubMed ID: 4565762
    [No Abstract]   [Full Text] [Related]  

  • 65. Power analysis for correlation of plasma level and clinical data.
    Davis JM; Wang Z
    Psychopharmacol Ser; 1993; 10():253-64. PubMed ID: 8103226
    [No Abstract]   [Full Text] [Related]  

  • 66. A comparative evaluation of drug interaction publications.
    Bell JE
    Am J Hosp Pharm; 1971 Dec; 28(12):938-44. PubMed ID: 5135188
    [No Abstract]   [Full Text] [Related]  

  • 67. Practical clinical trials for schizophrenia.
    Stroup S
    Epidemiol Psichiatr Soc; 2005; 14(3):132-6. PubMed ID: 16255159
    [No Abstract]   [Full Text] [Related]  

  • 68. The powerful cipher.
    Lasagna L
    Sciences (New York); 1980 Feb; 20(2):31-2. PubMed ID: 11662731
    [No Abstract]   [Full Text] [Related]  

  • 69. Dose selection and comparator drugs in schizophrenia research.
    Kane JM
    J Clin Psychiatry; 2001; 62 Suppl 9():29-32; discussion 33-4. PubMed ID: 11379828
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Relapse prevention in schizophrenia: evidence from longterm, randomized, double-blind clinical trials.
    Pecenak J
    Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():49-70. PubMed ID: 17262007
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
    Fowler JA; Bettinger TL; Argo TR
    Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Difficulties of evaluation of the results of drug treatment of schizophrenia].
    Welbel L
    Psychiatr Pol; 1980; 14(1):51-7. PubMed ID: 6102774
    [No Abstract]   [Full Text] [Related]  

  • 73. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.